Omniscience entered the PMS space with a Buffett, Graham-style philosophy, in 3 years at Rs. 1,000 crore AUM target

OmniScience Capital on Monday announced its entry into the fast-expanding PMS (Portfolio Management Services) industry, taking its assets under management (AUM) to Rs. 250 crore and in three years Rs. 1,000 crore was unveiled. The firm said its PMS suite will be designed for a broad base of sophisticated, research-oriented scientific investors.

As part of its PMS launch, OmniScience introduced three different product categories. Omni Crest, Omni Imperative and Omni Institutional. In the first series, the company will offer a foundational strategy leveraging Omniscience’s alpha-generation expertise. In the second category, it will offer scientific exposure to India’s unrelated infrastructure growth vectors while in the third category, the company will offer scientifically designed custom solutions for institutional investors.

The investment management company has gone live with 22 strategies that showcase proprietary, skin in the game, according to a media release.

Among these, Omni Inevitability represents a key innovation, the release said.

The company’s entry into the PMS segment was driven by the 5X growth of the industry in the last 5 years.

Founded by a team of IITians, OmniScience Capital has client assets of Rs. 1,000 crore claims to be an expert in scientific, research-led investment.

Omniscience said its asset management philosophy is grounded in a scientific investment framework – drawing inspiration from legends such as Benjamin Graham, Warren Buffett and Peter Lynch, yet deliberately moving beyond their traditional approaches.

“OmniScience prides itself on its vision of practicing investment management as a performance-focused business rather than an asset-gathering business. The company’s scientific investing framework, based on first-principles, has been applied to over Rs 10 billion (1,000 crore) of assets across multiple market cycles.

“When performance thrives, ecosystems win,” said Vikas V Gupta, CEO and Chief Investment Strategist at OmniScience Capital, which has built a unique science investment ecosystem of science investors, science partners and science managers.

The scientific investment approach of chasing safety in search of true alpha goes beyond the typical style-based approach in the PMS/AIF/MF industry, of growth, quality, value, momentum or size, each of which can be replicated in its own favorable cycle with masquerades as smart beta and alpha.

(Disclaimer: Recommendations, suggestions, opinions and views given by experts are their own. These do not represent the views of Economic Times.)